Q2 2024 Rapid Micro Biosystems Inc Earnings Call Transcript
Key Points
- Total revenue increased by 32% to $6.6 million, exceeding guidance and marking a record quarter.
- Placed five Growth Direct systems in Q2, including the first Rapid Sterility system.
- Gross margins showed significant improvement, nearing breakeven in Q2.
- Operational efficiency program expected to enable positive cash flow by the end of 2027 without additional financing.
- Strong customer interest and adoption of the Growth Direct system, with plans for further deployments.
- Net loss of $12.6 million in Q2, though an improvement from $14 million in Q2 last year.
- Product margins were still negative at -8%, despite improvements.
- Operating expenses remained high at $13.2 million, flat compared to the prior quarter.
- Uncertainty related to the timing and scale of customer purchase decisions affecting revenue guidance.
- Inventory levels increased slightly in the first half of the year, impacting working capital.
Thank you for standing by. My name is Dee, and I will be your conference operator today. At this time, I would like to welcome everyone to the Rapid Micro Biosystems' second-quarter 2024 earnings conference call. (Operator Instructions)
Thank you. I would now like to turn the call over to Michael Beaulieu with Investor Relations. Please go ahead.
Good morning, and thank you for joining the Rapid Micro Biosystems' second-quarter 2024 earnings call. Joining me on the call are Rob Spignesi, President and Chief Executive Officer; and Sean Wirtjes, Chief Financial Officer. Earlier today, we issued a press release announcing our second-quarter 2024 financial results. A copy of the release is available on the company's website at RapidMicroBio.com under Investors in the News and Events section.
Before we begin, I'd like to remind you that many statements made during this call may be considered forward-looking statements within the meaning of federal securities laws
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
